UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication ...

Ketamine, an anesthetic administered through infusions that can have psychedelic properties, has been hailed as a life-saving ...

Published in September in Molecular Psychiatry, the UB discovery will also help scientists identify how depression originates in the brain and will stimulate research into using ketamine and ...

For instance, regular use may lead to dependency or cognitive impairment, particularly if abused recreationally. This risk is a significant reason why ketamine for depression treatment is closely ...

Published in September in Molecular Psychiatry, the UB discovery will also help scientists identify how depression originates in the brain, and will stimulate research into using ketamine and ketamine ...

Heitler: If ketamine hasn’t been officially approved for depression, how can medical professionals ... it’s not widely used--perhaps because it must be administered in a doctor’s office ...

Reference Walsh, Mollaahmetoglu, Rootman, Golsof, Keeler and Marsh1 Current prescribing guidelines support the use of ketamine-based treatments for treatment-resistant depression, typically defined as ...

Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...

Acupuncture. Ketamine infusions. "Electroshock" or electroconvulsive therapy. The existing treatment options for those ...

PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced that the Company requested a post-complete letter clarification ...